As a result, we propose that Act suppressed the AKT/GSK-3β signaling pathway, which in turn reduced podocyte apoptosis, improved glomerular pathology, and eventually delayed the development of DKD in db/db mice. This evidence concerns the gene AKT1 and diabetic kidney disease.